ASSURA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.78 GBX | -0.88% |
|
+1.13% | -11.10% |
| May. 08 | UBS raises Centrica to 'buy' from 'neutral | AN |
| Apr. 12 | JPMorgan raises Taylor Wimpey, Persimmon | AN |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 147M 187M | Sales 2025 * | 153M 194M | Capitalization | 1.28B 1.62B |
|---|---|---|---|---|---|
| Net income 2024 * | -38M -48.26M | Net income 2025 * | 157M 199M | EV / Sales 2024 * | 16.9 x |
| Net Debt 2024 * | 1.2B 1.52B | Net Debt 2025 * | 1.24B 1.57B | EV / Sales 2025 * | 16.5 x |
| P/E ratio 2024 * |
42.8
x | P/E ratio 2025 * |
10
x | Employees | 86 |
| Yield 2024 * |
7.55% | Yield 2025 * |
7.81% | Free-Float | 99.76% |
More Fundamentals
* Assessed data
More news
Latest transcript on Assura Plc
More recommendations
More press releases
| 1 day | -0.88% | ||
| 1 week | +1.13% | ||
| Current month | +3.78% | ||
| 1 month | +6.42% | ||
| 3 months | +1.71% | ||
| 6 months | -6.14% | ||
| Current year | -11.10% |
1 week
41.40
43.78
1 month
40.0843.78
Current year
39.7449.04
1 year
38.3853.00
3 years
38.3880.60
5 years
38.3888.00
10 years
38.3888.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jonathan Murphy
CEO | Chief Executive Officer | 52 | 12-12-31 |
Jayne Cottam
DFI | Director of Finance/CFO | 50 | 17-08-03 |
Joanne Cullen
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Orla Ball
BRD | Director/Board Member | 53 | 15-03-31 |
Jonathan Davies
BRD | Director/Board Member | 62 | 18-05-31 |
Jonathan Murphy
CEO | Chief Executive Officer | 52 | 12-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.16% | 133 M€ | +6.76% | ||
| 0.03% | 746 M€ | -.--% | - | |
| 0.02% | 11 M€ | +5.93% | - | |
| 0.02% | 197 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 42.78 | -0.88% | 21,173,380 |
| 24-05-16 | 43.16 | -0.69% | 5,320,159 |
| 24-05-15 | 43.46 | +2.69% | 15,122,120 |
| 24-05-14 | 42.32 | -0.05% | 10,140,000 |
| 24-05-13 | 42.34 | +0.09% | 3,751,126 |
Delayed Quote London S.E., May 17, 2024 at 11:35 am EDT
More quotes
Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company specializes in the development of, investment in and management of a portfolio of primary care, diagnostic and treatment buildings across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care, and community healthcare buildings so the NHS has the places and spaces it needs to deliver more services, tests, and treatments in the community. The Company owns and manages a portfolio of about 612 properties. The Companyâs subsidiaries include Assura (SC1) Ltd, BHE (St James) Ltd, Assura PCP UK Ltd, Metro MRI Ltd, Upton Community Health Care Ltd, Cheltenham Family Health Care Centre Ltd, Upton Medical Ltd, Xantaris Investments (XXI) Ltd, Assura Services Ltd, Assura Primary Care Properties Ltd, Assura Trellech Ltd, and others.
Sector
Specialized REITs
Calendar
2024-05-20
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
0.4278
GBP
Average target price
0.505
GBP
Spread / Average Target
+18.05%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.10% | 1.62B | |
| +12.32% | 60.56B | |
| -1.87% | 19.76B | |
| +0.45% | 14B | |
| -0.10% | 7.57B | |
| -6.79% | 6.01B | |
| +12.06% | 3.56B | |
| +0.46% | 3.32B | |
| -4.32% | 3.15B | |
| +2.04% | 3.01B |
- Stock Market
- Equities
- AGR Stock
